Integration of CRISPR gene editing could improve the precision, speed and cost-effectiveness of cancer-fighting CAR T therapy
Category: pharma & healthcare
Holy Grail Of Precision Medicine – Co-Development Of Therapeutics And Companion Diagnostics – Hasn’t Yet Achieved Its Potential
Developing a novel biomarker test in parallel with a therapeutic, with the expectation that the biomarker is going to be included in the FDA-approved label, is accompanied by a set of significant scientific and commercialization challenges.
Symptomatic Covid-19 Infection Is Associated With An Increased Risk Of Overactive Bladder Symptoms
Symptomatic Covid-19 infection is associated with the risk of developing or worsening overactive bladder.
Reimagining Alzheimer’s (Part 6): The Many Effects Of The APOE4 Variant
A novel aspect of the APOE4 genetic predisposition to Alzheimer’s is uncovered and leads to the potential for new diagnostic methods and treatment
As Tripledemic Of Flu, RSV, And Covid-19 Surges Shortages Of Drugs Are Having A Disproportionate Impact On Children
Drug shortages are a persistent public health issue in the US. There is no easy method to scale up production to meet periodic sharp increases in demand, like the one occurring at the moment as a result of the “tripledemic.” And there is a limited prof…
Novartis And Medicines For Malaria Venture Make Important Progress On The Anti-Malarial Treatment Front
Should the Phase 3 trial prove successful, ganaplacide/lumefantrine could be an alternative to artemisinin-based treatments, which are being increasingly challenged by resistant strains of malaria. Indeed, as the world faces emerging resistance to curr…
NBA Legend Alonzo Mourning’s Journey From Kidney Scare To Health Advocate
With an NBA championship ring, 7 All-Star appearances and an Olympic gold medal, Alonzo Mourning was on top of the world. Until he wasn’t. The NBA legend is using his powerful platform to educate the public about kidney health, after his own battle wit…
Despite Eye-Popping $3.5 Million Price Tag For Gene Therapy Hemgenix, Budget Impact For Most Payers Will Be Relatively Small
The first gene therapy for hemophilia B, Hemgenix, will have a list price of $3.5 million per use. This sets a new record for the most expensive single-use gene therapy in the U.S. In spite of the very high price tag, the budgetary impact of the produc…
Crimean-Congo Hemorrhagic Fever Virus Monoclonal Antibodies: A Work In Progress
A recent study on Crimean-Congo Hemorrhagic Fever Virus may pave the way for a new monoclonal antibody treatment in the near future.
China Protests Go Beyond Demanding An End To Severe Covid-19 Restrictions
The BBC and other news outlets have called recent demonstrations in China “Covid protests.” But, the protests are not simply about stringent Covid-19 policies. Though triggered by ongoing lockdowns, the protests have a broader aim of ending authoritari…
